Speaking of Risk: Pharmaceutical Companies and Third Party Promotions

Pharmaceutical companies around the world are struggling to keep up with the rapid evolution of ethical frameworks around bribery and corruption in their industry.
Read More

Topics: Anti-bribery & Anti-corruption, Pharma, Pharmaceutical Companies, Bribery, Corruption, Medical Companies, DOJ, FCPA, SEC, settlement, fines, gsk, teva